Integrin αXβ2 is a leukocyte receptor for Candida albicans and is essential for protection against fungal infections

Journal of Immunology

Volumn 189, Issue 5, 2012, Pages 2468-2477

  Jawhara, Samir ^a   Pluskota, Elzbieta ^a   Verbovetskiy, Dmitriy ^a   Skomorovska Prokvolit, Olena ^b   Plow, Edward F ^a   Soloviev, Dmitry A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLUCAN; GLYCOPROTEIN P 15095; MANNAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIFUNGAL ACTIVITY; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARTICLE; BRAIN INFECTION; CANDIDA ALBICANS; CONTROLLED STUDY; FUNGAL STRAIN; FUNGAL VIRULENCE; FUNGUS HYPHAE; HEPATITIS; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; INFECTION PREVENTION; INOCULATION; INVASIVE CANDIDIASIS; LETHAL DOSE; MORTALITY; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; WILD TYPE;

ANIMALS; CANDIDA ALBICANS; CANDIDIASIS; CELL ADHESION; CELL LINE; CELL MOVEMENT; CYTOPHAGOCYTOSIS; HEK293 CELLS; HUMANS; INTEGRIN ALPHAXBETA2; LEUKOCYTES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; RECEPTORS, IMMUNOLOGIC;

EID: 84865428670     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1200524     Document Type: Article

References (96)

1. Chaffin, W. L., J. L. López-Ribot, M. Casanova, D. Gozalbo, and J. P. Martínez. 1998. Cell wall and secreted proteins of Candida albicans: identification, function, and expression. Microbiol. Mol. Biol. Rev. 62: 130-180.
2. Corner, B. E., and P. T. Magee. 1997. Candida pathogenesis: unravelling the threads of infection. Curr. Biol. 7: R691-R694.
3. Muhlschlegal, F., W. A. Fonzi, L. W. Hoyer, T. Payne, F. M. Poulet, J. Clevenger, J. P. Latgé, J. Calera, A. Beauvais, S. Paris, et al. 1998. Molecular mechanisms of virulence in fungus-host interactions for Aspergillus fumigatus and Candida albicans. Med. Mycol. 36(Suppl 1): 238-248.
4. Calderone, R. A., and W. A. Fonzi. 2001. Virulence factors of Candida albicans. Trends Microbiol. 9: 327-335.
5. Lo, H. J., J. R. Köhler, B. DiDomenico, D. Loebenberg, A. Cacciapuoti, and G. R. Fink. 1997. Nonfilamentous C. albicans mutants are avirulent. Cell 90: 939-949.
6. Saville, S. P., A. L. Lazzell, C. Monteagudo, and J. L. Lopez-Ribot. 2003. Engineered control of cell morphology in vivo reveals distinct roles for yeast and filamentous forms of Candida albicans during infection. Eukaryot. Cell 2: 1053-1060.
7. Snydman, D. R. 2003. Shifting patterns in the epidemiology of nosocomial Candida infections. Chest 123(Suppl. 5)500S-503S.
8. Abelson, J. A., T. Moore, D. Bruckner, J. Deville, and K. Nielsen. 2005. Frequency of fungemia in hospitalized pediatric inpatients over 11 years at a tertiary care institution. Pediatrics 116: 61-67.
9. Cole, G. T., A. A. Halawa, and E. J. Anaissie. 1996. The role of the gastrointestinal tract in hematogenous candidiasis: from the laboratory to the bedside. Clin. Infect. Dis. 22(Suppl. 2): 73-88.
10. Wingard, J. R. 1994. Infections due to resistant Candida species in patients with cancer who are receiving chemotherapy. Clin. Infect. Dis. 19(Suppl. 1): S49-S53.
11. Richardson, M. D. 2005. Changing patterns and trends in systemic fungal infections. J. Antimicrob. Chemother. 56(Suppl. 1): i5-i11.
12. Diamond, R. D. 1993. Interactions of phagocytic cells with Candida and other opportunistic fungi. Arch. Med. Res. 24: 361-369.
13. Netea, M. G., K. Gijzen, N. Coolen, I. Verschueren, C. G. Figdor, J. W. Van der Meer, R. Torensma, and B. J. Kullberg. 2004. Human dendritic cells are less potent at killing Candida albicans than both monocytes and macrophages. Microbes Infect. 6: 985-989.
14. Mahanty, S., R. A. Greenfield, W. A. Joyce, and P. W. Kincade. 1988. Inoculation candidiasis in a murine model of severe combined immunodeficiency syndrome. Infect. Immun. 56: 3162-3166.
15. Baghian, A., and K. W. Lee. 1988. Role of activated macrophages in resistance to systemic candidosis. J. Leukoc. Biol. 44: 166-171.
16. Bistoni, F., A. Vecchiarelli, E. Cenci, P. Puccetti, P. Marconi, and A. Cassone. 1986. Evidence for macrophage-mediated protection against lethal Candida albicans infection. Infect. Immun. 51: 668-674.
17. 2 integrins: moderators of life or death decisions. Trends Immunol. 26: 388-395.
18. + cytotoxic T cell activation and memory in virus infection. J. Immunol. 149: 1326-1333.
19. Arnaout, M. A., L. L. Lanier, and D. V. Faller. 1988. Relative contribution of the leukocyte molecules Mo1, LFA-1, and p150,95 (LeuM5) in adhesion of granulocytes and monocytes to vascular endothelium is tissue- and stimulus-specific. J. Cell. Physiol. 137: 305-309.
20. Larson, R. S., and T. A. Springer. 1990. Structure and function of leukocyte integrins. Immunol. Rev. 114: 181-217.
21. 2integrins. Adv. Exp. Med. Biol. 323: 171-179.
22. Stewart, M., M. Thiel, and N. Hogg. 1995. Leukocyte integrins. Curr. Opin. Cell Biol. 7: 690-696.
23. Harris, E. S., T. M. McIntyre, S. M. Prescott, and G. A. Zimmerman. 2000. The leukocyte integrins. J. Biol. Chem. 275: 23409-23412.
24. Bajtay, Z., C. Speth, A. Erdei, and M. P. Dierich. 2004. Cutting edge: productive HIV-1 infection of dendritic cells via complement receptor type 3 (CR3, CD11b/CD18). J. Immunol. 173: 4775-4778.
25. Kuijpers, T. W., E. van de Vijver, M. A. Weterman, M. de Boer, A. T. Tool, T. K. van den Berg, M. Moser, M. E. Jakobs, K. Seeger, O. Sanal, et al. 2009. LAD-1/variant syndrome is caused by mutations in FERMT3. Blood 113: 4740-4746.
26. Anderson, D. C., F. C. Schmalstieg, W. Shearer, K. Becker-Freeman, S. Kohl, C. W. Smith, M. F. Tosi, and T. Springer. 1985. Leukocyte LFA-1, OKM1, p150,95 deficiency syndrome: functional and biosynthetic studies of three kindreds. Fed. Proc. 44: 2671-2677.
27. Andrews, T., and K. E. Sullivan. 2003. Infections in patients with inherited defects in phagocytic function. Clin. Microbiol. Rev. 16: 597-621.
28. Klempner, M. S., and H. L. Malech. 2003. Phagocytes: normal and abnormal neutrophil host defenses. In Infectious Diseases, 3rd ed. S. L. Gorbach, J. G. Bartlett, and N. R. Blacklow, eds. Lippincott Williams & Wilkins, Philadelphia. p. 14-39.
29. Soloviev, D. A., S. Jawhara, and W. A. Fonzi. 2011. Regulation of innate immune response to Candida albicans infections by αMβ2-Pra1p interaction. Infect. Immun. 79: 1546-1558.
30. Brown, G. D., P. R. Taylor, D. M. Reid, J. A. Willment, D. L. Williams, L. Martinez-Pomares, S. Y. Wong, and S. Gordon. 2002. Dectin-1 is a major β-glucan receptor on macrophages. J. Exp. Med. 196: 407-412.
31. Netea, M. G., R. Sutmuller, C. Hermann, C. A. Van der Graaf, J. W. Van der Meer, J. H. van Krieken, T. Hartung, G. Adema, and B. J. Kullberg. 2004. Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells. J. Immunol. 172: 3712-3718.
32. Netea, M. G., C. A. Van Der Graaf, A. G. Vonk, I. Verschueren, J. W. Van Der Meer, and B. J. Kullberg. 2002. The role of toll-like receptor (TLR) 2 and TLR4 in the host defense against disseminated candidiasis. J. Infect. Dis. 185: 1483-1489.
33. Harokopakis, E., M. H. Albzreh, M. H. Martin, and G. Hajishengallis. 2006. TLR2 transmodulates monocyte adhesion and transmigration via Rac1- and PI3K-mediated inside-out signaling in response to Porphyromonas gingivalis fimbriae. J. Immunol. 176: 7645-7656.
34. Sorgi, C. A., A. Secatto, C. Fontanari, W. M. Turato, C. Belangér, A. I. de Medeiros, S. Kashima, S. Marleau, D. T. Covas, P. T. Bozza, and L. H. Faccioli. 2009. Histoplasma capsulatum cell wall β-glucan induces lipid body formation through CD18, TLR2, and dectin-1 receptors: correlation with leukotriene B4 generation and role in HIV-1 infection. J. Immunol. 182: 4025-4035.
35. Forsyth, C. B., and H. L. Mathews. 1996. Lymphocytes utilize CD11b/CD18 for adhesion to Candida albicans. Cell. Immunol. 170: 91-100.
36. Forsyth, C. B., E. F. Plow, and L. Zhang. 1998. Interaction of the fungal pathogen Candida albicans with integrin CD11b/CD18: recognition by the I domain is modulated by the lectin-like domain and the CD18 subunit. J. Immunol. 161: 6198-6205.
37. Sentandreu, M., M. V. Elorza, R. Sentandreu, and W. A. Fonzi. 1998. Cloning and characterization of PRA1, a gene encoding a novel pH-regulated antigen of Candida albicans. J. Bacteriol. 180: 282-289.
38. López-Ribot, J. L., P. Sepúlveda, A. M. Cervera, P. Roig, D. Gozalbo, and J. P. Martínez. 1997. Cloning of a cDNA fragment encoding part of the protein moiety of the 58-kDa fibrinogen-binding mannoprotein of Candida albicans. FEMS Microbiol. Lett. 157: 273-278.
39. Casanova, M., J. L. Lopez-Ribot, C. Monteagudo, A. Llombart-Bosch, R. Sentandreu, and J. P. Martinez. 1992. Identification of a 58-kilodalton cell surface fibrinogen-binding mannoprotein from Candida albicans. Infect. Immun. 60: 4221-4229.
40. 2. J. Immunol. 178: 2038-2046.
41. De Bernardis, F., F. A. Mühlschlegel, A. Cassone, and W. A. Fonzi. 1998. The pH of the host niche controls gene expression in and virulence of Candida albicans. Infect. Immun. 66: 3317-3325.
42. Ramon, A. M., A. Porta, and W. A. Fonzi. 1999. Effect of environmental pH on morphological development of Candida albicans is mediated via the PacC-related transcription factor encoded by PRR2. J. Bacteriol. 181: 7524-7530.
43. Luo, S., S. Poltermann, A. Kunert, S. Rupp, and P. F. Zipfel. 2009. Immune evasion of the human pathogenic yeast Candida albicans: Pra1 is a Factor H, FHL-1 and plasminogen binding surface protein. Mol. Immunol. 47: 541-550.
44. Hogg, N., and P. A. Bates. 2000. Genetic analysis of integrin function in man: LAD-1 and other syndromes. Matrix Biol. 19: 211-222.
45. Lanier, L. L., M. A. Arnaout, R. Schwarting, N. L. Warner, and G. D. Ross. 1985. p150/95, third member of the LFA-1/CR3 polypeptide family identified by anti-Leu M5 monoclonal antibody. Eur. J. Immunol. 15: 713-718.
46. Nham, S. U. 1999. Characteristics of fibrinogen binding to the domain of CD11c, an a subunit of p150,95. Biochem. Biophys. Res. Commun. 264: 630-634.
47. Frick, C., A. Odermatt, K. Zen, K. J. Mandell, H. Edens, R. Portmann, L. Mazzucchelli, D. L. Jaye, and C. A. Parkos. 2005. Interaction of ICAM-1 with b2-integrin CD11c/CD18: characterization of a peptide ligand that mimics a putative binding site on domain D4 of ICAM-1. Eur. J. Immunol. 35: 3610-3621.
48. Bilsland, C. A., M. S. Diamond, and T. A. Springer. 1994. The leukocyte integrin p150,95 (CD11c/CD18) as a receptor for iC3b. Activation by a heterologous beta subunit and localization of a ligand recognition site to the I domain. J. Immunol. 152: 4582-4589.
49. Rosas-Taraco, A. G., M. C. Salinas-Carmona, A. Revol, A. Rendon, G. Caballero-Olin, and A. Y. Arce-Mendoza. 2009. Expression of CDllc in blood monocytes as biomarker for favorable response to antituberculosis treatment. Arch. Med. Res. 40: 128-131.
50. Schlesinger, L. S., and M. A. Horwitz. 1991. Phagocytosis of Mycobacterium leprae by human monocyte-derived macrophages is mediated by complement receptors CR1 (CD35), CR3 (CD11b/CD18), and CR4 (CD11c/CD18) and IFN-γactivation inhibits complement receptor function and phagocytosis of this bacterium. J. Immunol. 147: 1983-1994.
51. Hellmig, S., S. Mascheretti, J. Renz, H. Frenzel, F. Jelschen, J. K. Rehbein, U. Fölsch, J. Hampe, and S. Schreiber. 2005. Haplotype analysis of the CD11 gene cluster in patients with chronic Helicobacter pylori infection and gastric ulcer disease. Tissue Antigens 65: 271-274.
52. Porta, A., A. M. Ramon, and W. A. Fonzi. 1999. PRR1, a homolog of Aspergillus nidulans palF, controls pH-dependent gene expression and filamentation in Candida albicans. J. Bacteriol. 181: 7516-7523.
53. Lu, H., C. W. Smith, J. Perrard, D. Bullard, L. Tang, S. B. Shappell, M. L. Entman, A. L. Beaudet, and C. M. Ballantyne. 1997. LFA-1 is sufficient in mediating neutrophil emigration in Mac-1-deficient mice. J. Clin. Invest. 99: 1340-1350.
54. Rosenkranz, A. R., A. Coxon, M. Maurer, M. F. Gurish, K. F. Austen, D. S. Friend, S. J. Galli, and T. N. Mayadas. 1998. Impaired mast cell development and innate immunity in Mac-1 (CD11b/CD18, CR3)-deficient mice. J. Immunol. 161: 6463-6467.
55. Ding, Z. M., J. E. Babensee, S. I. Simon, H. Lu, J. L. Perrard, D. C. Bullard, X. Y. Dai, S. K. Bromley, M. L. Dustin, M. L. Entman, et al. 1999. Relative contribution of LFA-1 and Mac-1 to neutrophil adhesion and migration. J. Immunol. 163: 5029-5038.
56. 2 (Mac-1) on neutrophil-derived microparticles. Blood 112: 2327-2335.
57. 2. J. Biol. Chem. 271: 29953-29957.
58. 2 integrins. J. Biol. Chem. 271: 18211-18216.
59. 2. J. Biol. Chem. 280: 1336-1345.
60. Kumar, C. C., H. Nie, C. P. Rogers, M. Malkowski, E. Maxwell, J. J. Catino, and L. Armstrong. 1997. Biochemical characterization of the binding of echistatin to integrin avb3 receptor. J. Pharmacol. Exp. Ther. 283: 843-853.
61. Forsyth, C. B., and H. L. Mathews. 2002. Lymphocyte adhesion to Candida albicans. Infect. Immun. 70: 517-527.
62. Rüchel, R., and M. Schaffrinski. 1999. Versatile fluorescent staining of fungi in clinical specimens by using the optical brightener Blankophor. J. Clin. Microbiol. 37: 2694-2696.
63. Soloviev, D. A., E. Pluskota, and E. F. Plow. 2006. Cell adhesion and migration assays. In Methods in Molecular Medicine. Q. Wang, ed. Vol. 129. Humana Press, Totowa, NJ, p. 267-278.
64. 2 orchestrates and accelerates plasminogen activation and fibrinolysis by neutrophils. J. Biol. Chem. 279: 18063-18072.
65. 2-mediated cell migration to fibrinogen and its recognition peptides. J. Exp. Med. 193: 1123-1133.
66. Lehrer, R. I., and M. J. Cline. 1969. Interaction of Candida albicans with human leukocytes and serum. J. Bacteriol. 98: 996-1004.
67. MacCallum, D. M., and F. C. Odds. 2005. Temporal events in the intravenous challenge model for experimental Candida albicans infections in female mice. Mycoses 48: 151-161.
68. Aldred, A. J., M. C. Cha, and K. A. Meckling-Gill. 2002. Determination of a humane endpoint in the L1210 model of murine leukemia. Contemp. Top. Lab. Anim. Sci. 41: 24-27.
69. Spellberg, B., A. S. Ibrahim, J. E. Edwards, Jr., and S. G. Filler. 2005. Mice with disseminated candidiasis die of progressive sepsis. J. Infect. Dis. 192: 336-343.
70. Ross, G. D., J. A. Cain, and P. J. Lachmann. 1985. Membrane complement receptor type three (CR3) has lectin-like properties analogous to bovine conglutinin as functions as a receptor for zymosan and rabbit erythrocytes as well as a receptor for iC3b. J. Immunol. 134: 3307-3315.
71. 2 for a specific and high affinity ligand, NIF. J. Biol. Chem. 272: 17558-17564.
72. 2 within the γ-chain of fibrinogen. J. Biol. Chem. 273: 22519-22527.
73. Ginsburg, I., M. N. Sela, A. Morag, Z. Ravid, Z. Duchan, M. Ferne, S. Rabinowitz-Bergner, P. P. Thomas, P. Davies, J. Niccols, et al. 1981. Role of leukocyte factors and cationic polyelectrolytes in phagocytosis of group A streptococci and Candida albicans by neutrophils, macrophages, fibroblasts and epithelial cells: modulation by anionic polyelectrolytes in relation to pathogenesis of chronic inflammation. Inflammation 5: 289-312.
74. Bodo, M., E. Becchetti, T. Baroni, S. Mocci, L. Merletti, M. Giammarioli, M. Calvitti, and G. Sbaraglia. 1995. Internalization of Candida albicans and cytoskeletal organization in macrophages and fibroblasts treated with concanavalin A. Cell. Mol. Biol. (Noisy-le-grand) 41: 297-305.
75. Margadant, C., H. N. Monsuur, J. C. Norman, and A. Sonnenberg. 2011. Mechanisms of integrin activation and trafficking. Curr. Opin. Cell Biol. 23: 607-614.
76. Becher, B., and J. P. Antel. 1996. Comparison of phenotypic and functional properties of immediately ex vivo and cultured human adult microglia. Glia 18: 1-10.
77. Jong, A. Y., M. F. Stins, S. H. Huang, S. H. Chen, and K. S. Kim. 2001. Traversal of Candida albicans across human blood-brain barrier in vitro. Infect. Immun. 69: 4536-4544.
78. Liu, Y., R. Mittal, N. V. Solis, N. V. Prasadarao, and S. G. Filler. 2011. Mechanisms of Candida albicans trafficking to the brain. PLoS Pathog. 7: e1002305.
79. Naito, M., G. Hasegawa, and K. Takahashi. 1997. Development, differentiation, and maturation of Kupffer cells. Microsc. Res. Tech. 39: 350-364.
80. Lawson, L. J., V. H. Perry, and S. Gordon. 1992. Turnover of resident microglia in the normal adult mouse brain. Neuroscience 48: 405-415.
81. 2integrins. J. Neuroimmunol. 30: 81-93.
82. Helmy, K. Y., K. J. Katschke, Jr., N. N. Gorgani, N. M. Kljavin, J. M. Elliott, L. Diehl, S. J. Scales, N. Ghilardi, and M. van Lookeren Campagne. 2006. CRIg: a macrophage complement receptor required for phagocytosis of circulating pathogens. Cell 124: 915-927.
83. Hinglais, N., M. D. Kazatchkine, C. Mandet, M. D. Appay, and J. Bariety. 1989. Human liver Kupffer cells express CR1, CR3, and CR4 complement receptor antigens: an immunohistochemical study. Lab. Invest. 61: 509-514.
84. Lionakis, M. S., J. K. Lim, C. C. Lee, and P. M. Murphy. 2011. Organ-specific innate immune responses in a mouse model of invasive candidiasis. J. Innate Immun. 3: 180-199.
85. Redmond, H. P., J. Shou, H. J. Gallagher, C. J. Kelly, and J. M. Daly. 1993. Macrophage-dependent candidacidal mechanisms in the murine system: comparison of murine Kupffer cell and peritoneal macrophage candidacidal mechanisms. J. Immunol. 150: 3427-3433.
86. Blasi, E., R. Mazzolla, R. Barluzzi, and F. Bistoni. 1991. Microglial cell-mediated anti-Candida activity: temperature, ions, protein kinase C as crucial elements. J. Neuroimmunol. 34: 53-60.
87. Neglia, R., B. Colombari, S. Peppoloni, C. Orsi, A. Tavanti, S. Senesi, and E. Blasi. 2006. Adaptive response of microglial cells to in vitro infection by Candida albicans isolates with different genomic backgrounds. Microb. Pathog. 41: 251-256.
88. Toth, C. A., and P. Thomas. 1992. Liver endocytosis and Kupffer cells. Hepatology 16: 255-266.
89. Yan, J., V. Vetvicka, Y. Xia, M. Hanikýrová, T. N. Mayadas, and G. D. Ross. 2000. Critical role of Kupffer cell CR3 (CD11b/CD18) in the clearance of IgMopsonized erythrocytes or soluble β-glucan. Immunopharmacology 46: 39-54.
90. Vetvicka, V., B. Dvorak, J. Vetvickova, J. Richter, J. Krizan, P. Sima, and J.-C. Yvin. 2007. Orally administered marine (1→3)-β-D-glucan Phycarine stimulates both humoral and cellular immunity. Int. J. Biol. Macromol. 40: 291-298.
91. Chan, G. C., W. K. Chan, and D. M. Sze. 2009. The effects of β-glucan on human immune and cancer cells. J Hematol Oncol 2: 25.
92. O'Brien, X. M., K. E. Heflin, L. M. Lavigne, K. Yu, M. Kim, A. R. Salomon, and J. S. Reichner. 2012. Lectin site ligation of CR3 induces conformational changes and signaling. J. Biol. Chem. 287: 3337-3348.
93. Thornton, B. P., V. Větvicka, M. Pitman, R. C. Goldman, and G. D. Ross. 1996. Analysis of the sugar specificity and molecular location of the β-glucan-binding lectin site of complement receptor type 3 (CD11b/CD18). J. Immunol. 156: 1235-1246.
94. Xia, Y., V. Vetvicka, J. Yan, M. Hanikýrová, T. Mayadas, and G. D. Ross. 1999. The β-glucan-binding lectin site of mouse CR3 (CD11b/CD18) and its function in generating a primed state of the receptor that mediates cytotoxic activation in response to iC3b-opsonized target cells. J. Immunol. 162: 2281-2290.
95. 2-integrin glycoprotein. Crit. Rev. Immunol. 20: 197-222.
96. Agarwal, S., C. A. Specht, H. Huang, G. R. Ostroff, S. Ram, P. A. Rice, and A. Levitzki. 2011. Linkage specificity and role of properdin in activation of the alternative complement pathway by fungal glycans. MBio 2: e00178-11.